{"organizations": [], "uuid": "3431b0dfefc762c9a2776766e5237ebd5f4d47c8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180413.html", "section_title": "Archive News &amp; Video for Friday, 13 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-henan-lingrui-pharmaceutical-to-ac/brief-henan-lingrui-pharmaceutical-to-acquire-33-33-pct-stake-in-biological-pharmaceutical-firm-for-66-7-mln-yuan-idUSL3N1RQ43D", "country": "US", "domain_rank": 408, "title": "BRIEF-Henan Lingrui Pharmaceutical to acquire 33.33 pct stake in biological pharmaceutical firm for 66.7 mln yuan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-13T17:26:00.000+03:00", "replies_count": 0, "uuid": "3431b0dfefc762c9a2776766e5237ebd5f4d47c8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-henan-lingrui-pharmaceutical-to-ac/brief-henan-lingrui-pharmaceutical-to-acquire-33-33-pct-stake-in-biological-pharmaceutical-firm-for-66-7-mln-yuan-idUSL3N1RQ43D", "ord_in_thread": 0, "title": "BRIEF-Henan Lingrui Pharmaceutical to acquire 33.33 pct stake in biological pharmaceutical firm for 66.7 mln yuan", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-henan lingrui pharmaceutical", "sentiment": "negative"}, {"name": "reuters) - henan lingrui pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 13(Reuters) - Henan Lingrui Pharmaceutical Co Ltd\n* Says it plans to acquire 33.33 percent stake in a biological pharmaceutical firm for 66.7 million yuan\n* Says it will increase stake in the biological pharmaceutical firm to 90.5 percent\nSource text in Chinese: goo.gl/wLnV3P\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "https://goo.gl/wLnV3P", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-13T17:26:00.000+03:00", "crawled": "2018-04-14T13:36:36.001+03:00", "highlightTitle": ""}